Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
OXB:PZNEX Exchange

Oxford Biomedica PLC

COMPANY INFO
685.00GBp
Market Closed
As of 08/16/2019 EDT
Open
685.00
Prev Close
685.00
Volume
0
Market Cap
525.861M
Day Range
685.00685.00
52 Week Range
630.00935.00
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio55.48
Bloomberg (BEst) P/E Ratio50.0000
Bloomberg (BEst) PEG Ratio--
Shares Outstanding76.77M
Price to Book Ratio12.2728
Price to Sales Ratio6.2909
1 Year Return-17.96%
30 Day Avg Volume--
EPS--
Bloomberg (BEst) EPS Curr Yr0.0790
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending S1/2019:09/04/2019

About Oxford Biomedica PLC

Oxford Biomedica is a gene and cell therapy group focused on developing treatments for serious diseases based around its FDA approved lentiviral vector delivery platform. The Company leverages this platform to develop in vivo and ex vivo products in-house and with global Pharmaceutical and Biotech partners and has created it's own portfolio of gene and cell therapy product candidates.
Address
Medawar Ctr Robert Robinson Avenue Oxford Science Park United Kingdom
Phone
44-1865-783-000
Website
www.oxfordbiomedica.co.uk

Income Statement

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions GBP)
  • Revenue
    --
  • Net Income
    --
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions GBP)
  • Total Assets
    --
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions GBP)
  • Operating
    --
  • Investing
    --
  • Financing
    --